Researchers have grown "mini brains" -- small three-dimensional tissues which resemble the structure and organisation of the developing human brain -- to study complicated brain disorders and discover novel treatment options.
These "mini brains" offer insight into the processes with which individual nerve cells organise themselves into our highly complex tissues, the researchers said.
"The method thus opens up completely new opportunities for investigating disorders in the architecture of the developing human brain," said lead researcher Julia Ladewig from the Institute of Reconstructive Neurobiology at the University of Bonn in Germany.
For the study, the researchers converted skin cells from patients into so-called induced pluripotent stem cells.
From these 'jack-of-all-trades' cells, they generated the brain organoids, according to the study published in the journal Cell Reports.
In their work, the scientists investigated the Miller-Dieker syndrome. This hereditary disorder is attributed to a chromosome defect.
As a consequence, patients present malformations of important parts of their brain.
"In patients, the surface of the brain is hardly grooved but instead more or less smooth," Vira Iefremova, who is also from University of Bonn, explained.
What causes these changes has so far only been known in part.
The researchers produced induced pluripotent stem cells from skin cells from Miller-Dieker patients, from which they then grew brain organoids.
"We were able to show that the stem cells divide differently in these patients," Philipp Koch, Associate Professor at the University of Bonn.
"In healthy people, the stem cells initially extensively multiply and form organised, densely packed layers. Only a small proportion of them becomes differentiated and develops into nerve cells," Koch said.
The researchers believe that organoids could herald a new era in brain research.
"And if we better understand the development of our brain, new treatment options for disorders of the brain can presumably arise from this over the long term," Ladewig said.
--IANS
gb/dg
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
